Suitability of the cynomolgus monkey as an animal model for drug absorption studies of oral dosage forms from the viewpoint of gastrointestinal physiology

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 10, 2003, Pages 1442-1447

  Ikegami, Kengo ^a   Tagawa, Kozo ^a   Narisawa, Shinji ^a   Osawa, Takashi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Animal model; Cynomolgus monkey; Gastrointestinal physiology; Oral dosage form

Indexed keywords

PARACETAMOL; DRUG;

ACIDITY; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIET RESTRICTION; DOG; DRUG ABSORPTION; DRUG DOSE REGIMEN; EVALUATION; FEEDING; FIBEROSCOPE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IN VIVO STUDY; INTESTINE TRANSIT TIME; MONKEY; NONHUMAN; STOMACH EMPTYING; STOMACH PH; ANIMAL; ANIMAL MODEL; DRUG DOSAGE FORM; DRUG EFFECT; GASTROINTESTINAL TRACT; INTESTINE ABSORPTION; MACACA; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; ANIMALS; DOSAGE FORMS; GASTROINTESTINAL TRACT; INTESTINAL ABSORPTION; MACACA FASCICULARIS; MALE; MODELS, ANIMAL; PHARMACEUTICAL PREPARATIONS;

EID: 1542436531     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.1442     Document Type: Article

References (30)

1. Uchida T., Kawata M., Goto S., J. Pharmacobio-Dyn., 9, 631-637 (1986).
2. Akimoto M., Furuya A., Maki T., Yamada K., Suwa T., Ogata H., Int. J. Pharmaceut., 100, 133-142 (1993).
3. Murata S., Ueda S., Shimojo F., Tokunaga Y., Hata T., Ohnishi N., Int. J. Pharmaceut., 161, 161-168 (1998).
4. Lin J. H., Drug Metab. Dispos., 23, 1008-1021 (1995).
5. Katori N., Aoyagi N., Terao T., Pharm. Res., 12, 237-243 (1995).
6. Dressman J. B., Pharm. Res., 3, 123-131 (1986).
7. Sagara K., Yamada I., Matsuura Y., Kawata M., Shibata M., Biol. Pharm. Bull., 19, 1184-1188 (1996).
8. Morimoto M., Yamashita K., Koyama H., Fujimoto H., Toguchi H., Kitamori N., Chem. Pharm. Bull., 34, 1257-1263 (1986).
9. Riegelman S., Collier P., J. Pharmacokinet. Biopharm., 8, 509-534 (1980).
10. Yamaoka Y., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).
11. Verotta D., J. Pharmacokinet. Biopharm., 17, 269-289 (1986).
12. Mizuta H., Kawazoe Y., Haga K., Ogawa K., Chem. Pharm. Bull., 38, 2224-2227 (1990).
13. Lin J. H., Drug. Metab. Dispos., 23, 1008-1021 (1986).
14. Kararli T. T., Biopharm. Drug Dispos., 16, 351-380 (1995).
15. Russell T. L., Berardi R. R., Barnett J. L., Dermentzoglou L. C., Jarvenpoa K. M., Schmaltz S. P., Dressman J. B., Pharm. Res., 10, 187-196 (1993).
16. Smith H. W., J. Pathol. Bacteriol., 89, 95-122 (1965).
17. Heading R. C., Nimmo J., Prescott L. F., Tothill P., Br. J. Pharmacol., 47, 415-421 (1973).
18. Muir N., Nichols J. D., Clifford J. M., Stillings M. R., Hoare R., Curr. Med. Res. Opin., 13, 491-495 (1997).
19. Hirate J., Zhu C. Y., Horikoshi I., Bhargava V. O., Biopharm. Drug Dispos., 11, 245-252 (1990).
20. Yamada K., Furuya A., Akimoto M., Maki T., Suwa T., Ogata H., Int. J. Pharmaceut., 119, 1-10 (1995).
21. Kaniwa N., Aoyagi N., Ogata H., Ejima A., J. Pharmacobio-Dyn., 11, 563-570 (1988).
22. Kamba M., Seta Y., Kusai A., Ikeda M., Nishimura K., Int. J. Pharmaceut., 208, 61-70 (2000).
23. Kamba M., Seta Y., Kusai A., Nishimura K., Int. J. Pharmaceut., 228, 209-217 (2001).
24. Kamba M., Seta Y., Kusai A., Nishimura K., Int. J. Pharmaceut., 237, 139-149 (2001).
25. Schroder H., Campbell D. E. S., Clin. Pharmacol. Ther., 13, 539-551 (1972).
26. Mizuta H., Kawazoe Y., Haga K., Ogawa T., Yokobe T., Yakugaku Zasshi, 109, 760-765 (1989).
27. Sagara K., Nagamatsu Y., Yamada I., Kawata M., Mizuta H., Ogawa K., Chem. Pharm. Bull., 40, 3303-3306 (1992).
28. Staniforth D. H., Coates P., Clarke J. G. N., Int. J. Clin. Pharmacol. Ther. Toxicol., 25, 406-409 (1987).
29. Davis S. S., Hardy J. G., Fare J. W., Gut, 27, 886-892 (1986).
30. Hashida M. (ed.), "Design and Evaluation of Oral Dosage Forms," Yakugyo Jiho, Japan, 1995.